Plan for Microwave Thermal Field
Research on Intelligent System of Plan for Microwave Thermal Field for Hepatocellular Carcinoma
1 other identifier
interventional
5
1 country
1
Brief Summary
Develop an intelligent system based on contrast-enhanced ultrasound and clinical information to help doctors automatically obtain ablation parameters (ablation needle number, ablation needle type, ablation time,ablation power) when preparing to use microwave ablation to treat hepatocellular carcinoma
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable hepatocellular-carcinoma
Started Oct 2021
Shorter than P25 for not_applicable hepatocellular-carcinoma
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2021
CompletedFirst Submitted
Initial submission to the registry
February 27, 2022
CompletedFirst Posted
Study publicly available on registry
March 8, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2022
CompletedMarch 8, 2022
February 1, 2022
1.2 years
February 27, 2022
March 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
MRI within 3 days after ablation
Postoperative MRI is used to determine whether the ablation zone completely covers the tumor and whether the size is appropriate
MRI within 3 days after ablation
local tumor progression
Follow up to observe whether local tumor progression occurs within 6 months after ablation
6 months
Study Arms (1)
HCC patients guided by Plan for Microwave Thermal Field
EXPERIMENTALThe plan for HCC patients undergoing microwave ablation would be refer to Plan for Microwave Thermal Field system
Interventions
When HCC patients undergo microwave ablation, the doctor will refer to the ablation plan provided by the system.If the plan is consistent with what the doctor thinks, follow the plan provided by the system. If the protocol is not consistent with what the doctor thinks, the doctor will revise the protocol.
Eligibility Criteria
You may qualify if:
- Biopsy or clinical diagnosis of HCC
- Complete clinical information and preoperative CEUS
- Curative treatment
You may not qualify if:
- Palliative care
- Intolerance to ablation
- Severe coagulation disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chinese PLA General Hospital
Beijing, Beijing Municipality, 100853, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D.
Study Record Dates
First Submitted
February 27, 2022
First Posted
March 8, 2022
Study Start
October 1, 2021
Primary Completion
December 30, 2022
Study Completion
December 30, 2022
Last Updated
March 8, 2022
Record last verified: 2022-02